That the House of Representatives— (1) supports the designation of Pulmonary Fibrosis Awareness Month ; (2) supports the goals and ideals of Pulmonary Fibrosis Awareness Month ; (3) continues to support and advocate for more robust and accelerated private, State, and Federal research to develop more effective treatments and therapies for pulmonary fibrosis and to ultimately discover a cure for this lethal disease; (4) continues to support and advocate for effective Federal efforts to ease the administrative burdens on those suffering from pulmonary fibrosis and their families and caregivers; (5) continues to support and advocate for swift and efficient Federal evaluation and approval of new drugs and other treatment options for pulmonary fibrosis patients; (6) recognizes the ongoing courage and contributions of individuals with pulmonary fibrosis who participate in vital, invaluable clinical trials to advance the knowledge of the disease; and (7) commends and encourages the continued dedication of organizations, volunteers, researchers, clinicians, rehabilitation professionals, and dedicated individuals in the United States and abroad working tirelessly to improve the quality of life for individuals with pulmonary fibrosis and the families and caregivers of those individuals.